{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:54:13Z","timestamp":1791309253077,"version":"4.3.1"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R01 GM097117"],"award-info":[{"award-number":["NIH R01 GM097117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["CDA 11\u2010217"],"award-info":[{"award-number":["CDA 11\u2010217"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["IIR 16\u2010024"],"award-info":[{"award-number":["IIR 16\u2010024"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Opioids are commonly prescribed to manage pain associated with inflammatory bowel disease (<jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content>). It is unknown what percentage of patients develop new persistent opioid use following a steroid\u2010treated <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> flare.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To identify the incidence and the predictors of new persistent opioid use following an <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> flare.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used a national insurance claim dataset to identify patients with <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> who received an opioid medication around the time of a corticosteroid\u2010treated <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> flare. Patients were stratified as previously opioid na\u00efve, intermittent users, or chronic users. The incidence of persistent opioid use among the opioid\u2010na\u00efve cohort was evaluated along with associated predictors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 15\u00a0119 <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> patients who received opioids around the time of a flare. 5411 (35.8%) were opioid\u2010na\u00efve patients of which 35.0% developed persistent opioid use after the flare. Factors associated with new persistent opioid use include a history of depression (hazard ratio [<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>] 1.29, 95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>] 1.13\u20101.47), substance abuse (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 1.36, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 1.2\u20101.54), chronic obstructive pulmonary disease (<jats:styled-content style=\"fixed-case\">COPD<\/jats:styled-content>) (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 1.17, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 1.04\u20101.3), as well as, Crohn's disease (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 1.26, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 1.14\u20101.4) or indeterminate colitis (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 1.6, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 1.36\u20101.88).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>New persistent opioid use is common in <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> patients who experience a flare, especially among those with mental health disorders, <jats:styled-content style=\"fixed-case\">COPD<\/jats:styled-content>, and Crohn's disease or indeterminate colitis. These findings can be helpful in risk\u2010stratifying patients when choosing an acute pain therapy and providing counselling before choosing to prescribe opioids to opioid\u2010na\u00efve patients experiencing an <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> flare.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.15023","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T08:40:19Z","timestamp":1542271219000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids"],"prefix":"10.1111","volume":"49","author":[{"given":"Mohamed","family":"Noureldin","sequence":"first","affiliation":[{"name":"Department of Internal Medicine Division of Gastroenterology and Hepatology Michigan Medicine University of Michigan Ann Arbor Michigan"},{"name":"Veterans Affairs Center for Clinical Management Research Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D. R.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Division of Gastroenterology and Hepatology Michigan Medicine University of Michigan Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shail M.","family":"Govani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Division of Gastroenterology The University of Texas Health Science Center at San Antonio San Antonio Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Cohen\u2010Mekelburg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Division of Gastroenterology and Hepatology Michigan Medicine University of Michigan Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke C.","family":"Kenney","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Michigan Ann Arbor Michigan"},{"name":"Michigan Opioid Prescribing Engagement Network University of Michigan Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9638-2186","authenticated-orcid":false,"given":"Ryan W.","family":"Stidham","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Division of Gastroenterology and Hepatology Michigan Medicine University of Michigan Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Waljee","sequence":"additional","affiliation":[{"name":"Department of Surgery University of Michigan Ann Arbor Michigan"},{"name":"Michigan Opioid Prescribing Engagement Network University of Michigan Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1964-8790","authenticated-orcid":false,"given":"Akbar K.","family":"Waljee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Division of Gastroenterology and Hepatology Michigan Medicine University of Michigan Ann Arbor Michigan"},{"name":"Veterans Affairs Center for Clinical Management Research Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.10.022"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-008-3567-2"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22360"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsr.2014.09.001"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10com06560"},{"key":"e_1_2_7_7_1","first-page":"e41","article-title":"Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000\u20132010","volume":"6","author":"Kenan K","year":"2012","journal-title":"Open Med"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-5-201109060-00011"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.391"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2013-101401"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02468.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.06.013"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.230"},{"key":"e_1_2_7_14_1","first-page":"e170504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett CM","year":"2017","journal-title":"JAMA"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28586-5"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3040-7"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.12.003"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21822"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3945"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12865"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.1827"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.01.475"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-2-201001190-00006"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy222"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12762"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14503"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12448"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14832"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20847"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6905"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1515917"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001084"},{"key":"e_1_2_7_35_1","first-page":"592","article-title":"Managing pain in inflammatory bowel disease","volume":"7","author":"Docherty MJ","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X12446158"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(15)30590-4"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.15023","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.15023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T06:46:04Z","timestamp":1693982764000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.15023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/apt.15023"],"URL":"https:\/\/doi.org\/10.1111\/apt.15023","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"2018-08-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}